Header Logo

Connection

Ashish Ranjan to Adjuvants, Immunologic

Back to Details
This is a "connection" page, showing publications Ashish Ranjan has written about Adjuvants, Immunologic.
Ashish Ranjan
Connection Strength
0.654
Adjuvants, Immunologic
  1. Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy. Pharmacol Ther. 2020 03; 207:107456.
    View in: PubMed
    Score: 0.654
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.